A Detailed Analysis of the Opioid Analgesics Market Influenced by an Expanding Aging Population, Rising Prevalence of Chronic Pain Conditions, and Advent of Pharmaceutical R&D
Report ID: PMRREP33953
Number of Pages: 189
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: January-2024
1. Executive Summary
1.1. Global Opioid Analgesics Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Drug Class Lifecycle Analysis
2.4. Opioid Analgesics Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Opioid Analgesics Market Outlook: Drug Class
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drug Class, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
3.3.3.1. Morphine
3.3.3.2. Codeine
3.3.3.3. Fentanyl
3.3.3.4. Meperidine
3.3.3.5. Methadone
3.3.3.6. Tramadol
3.3.3.7. Oxycodone
3.3.3.8. Dextromethorphan
3.3.3.9. Buprenorphine
3.3.3.10. Others
3.4. Market Attractiveness Analysis: Drug Class
3.5. Global Opioid Analgesics Market Outlook: Indication
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Indication, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
3.5.3.1. Surgical Pain
3.5.3.2. Cancer Pain
3.5.3.3. Neuropathic Pain
3.5.3.4. Other
3.6. Market Attractiveness Analysis: Indication
3.7. Global Opioid Analgesics Market Outlook: Route of Administration
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Route of Administration, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
3.7.3.1. Oral
3.7.3.2. Parenteral
3.7.3.3. Transdermal
3.7.3.4. Other
3.8. Market Attractiveness Analysis: Route of Administration
3.9. Global Opioid Analgesics Market Outlook: End User
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.9.3.1. Hospitals
3.9.3.2. Retail Pharmacies
3.9.3.3. Drug Stores
3.9.3.4. Online Pharmacies
3.10. Market Attractiveness Analysis: End User
4. Global Opioid Analgesics Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Drug Class
5.3.3. By Indication
5.3.4. By Route of Administration
5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
5.5.1. Morphine
5.5.2. Codeine
5.5.3. Fentanyl
5.5.4. Meperidine
5.5.5. Methadone
5.5.6. Tramadol
5.5.7. Oxycodone
5.5.8. Dextromethorphan
5.5.9. Buprenorphine
5.5.10. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
5.6.1. Surgical Pain
5.6.2. Cancer Pain
5.6.3. Neuropathic Pain
5.6.4. Other
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
5.7.1. Oral
5.7.2. Parenteral
5.7.3. Transdermal
5.7.4. Other
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.8.1. Hospitals
5.8.2. Retail Pharmacies
5.8.3. Drug Stores
5.8.4. Online Pharmacies
5.9. Market Attractiveness Analysis
6. Europe Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Drug Class
6.3.3. By Indication
6.3.4. By Route of Administration
6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
6.5.1. Morphine
6.5.2. Codeine
6.5.3. Fentanyl
6.5.4. Meperidine
6.5.5. Methadone
6.5.6. Tramadol
6.5.7. Oxycodone
6.5.8. Dextromethorphan
6.5.9. Buprenorphine
6.5.10. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
6.6.1. Surgical Pain
6.6.2. Cancer Pain
6.6.3. Neuropathic Pain
6.6.4. Other
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
6.7.1. Oral
6.7.2. Parenteral
6.7.3. Transdermal
6.7.4. Other
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.8.1. Hospitals
6.8.2. Retail Pharmacies
6.8.3. Drug Stores
6.8.4. Online Pharmacies
6.9. Market Attractiveness Analysis
7. East Asia Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Drug Class
7.3.3. By Indication
7.3.4. By Route of Administration
7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
7.5.1. Morphine
7.5.2. Codeine
7.5.3. Fentanyl
7.5.4. Meperidine
7.5.5. Methadone
7.5.6. Tramadol
7.5.7. Oxycodone
7.5.8. Dextromethorphan
7.5.9. Buprenorphine
7.5.10. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
7.6.1. Surgical Pain
7.6.2. Cancer Pain
7.6.3. Neuropathic Pain
7.6.4. Other
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
7.7.1. Oral
7.7.2. Parenteral
7.7.3. Transdermal
7.7.4. Other
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.8.1. Hospitals
7.8.2. Retail Pharmacies
7.8.3. Drug Stores
7.8.4. Online Pharmacies
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Drug Class
8.3.3. By Indication
8.3.4. By Route of Administration
8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
8.5.1. Morphine
8.5.2. Codeine
8.5.3. Fentanyl
8.5.4. Meperidine
8.5.5. Methadone
8.5.6. Tramadol
8.5.7. Oxycodone
8.5.8. Dextromethorphan
8.5.9. Buprenorphine
8.5.10. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
8.6.1. Surgical Pain
8.6.2. Cancer Pain
8.6.3. Neuropathic Pain
8.6.4. Other
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
8.7.1. Oral
8.7.2. Parenteral
8.7.3. Transdermal
8.7.4. Other
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.8.1. Hospitals
8.8.2. Retail Pharmacies
8.8.3. Drug Stores
8.8.4. Online Pharmacies
8.9. Market Attractiveness Analysis
9. Latin America Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Drug Class
9.3.3. By Indication
9.3.4. By Route of Administration
9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
9.5.1. Morphine
9.5.2. Codeine
9.5.3. Fentanyl
9.5.4. Meperidine
9.5.5. Methadone
9.5.6. Tramadol
9.5.7. Oxycodone
9.5.8. Dextromethorphan
9.5.9. Buprenorphine
9.5.10. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
9.6.1. Surgical Pain
9.6.2. Cancer Pain
9.6.3. Neuropathic Pain
9.6.4. Other
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
9.7.1. Oral
9.7.2. Parenteral
9.7.3. Transdermal
9.7.4. Other
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.8.1. Hospitals
9.8.2. Retail Pharmacies
9.8.3. Drug Stores
9.8.4. Online Pharmacies
9.9. Market Attractiveness Analysis
10. Middle East & Africa Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Drug Class
10.3.3. By Indication
10.3.4. By Route of Administration
10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
10.5.1. \Morphine
10.5.2. Codeine
10.5.3. Fentanyl
10.5.4. Meperidine
10.5.5. Methadone
10.5.6. Tramadol
10.5.7. Oxycodone
10.5.8. Dextromethorphan
10.5.9. Buprenorphine
10.5.10. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030
10.6.1. Surgical Pain
10.6.2. Cancer Pain
10.6.3. Neuropathic Pain
10.6.4. Other
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
10.7.1. Oral
10.7.2. Parenteral
10.7.3. Transdermal
10.7.4. Other
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.8.1. Hospitals
10.8.2. Retail Pharmacies
10.8.3. Drug Stores
10.8.4. Online Pharmacies
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Pfizer Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Abbott Laboratories
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Novartis AG
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Bayer AG
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. GlaxoSmithKline plc
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. F. Hoffmann-La Roche AG
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Boehringer Ingelheim International GmbH
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Bausch Health Companies Inc.
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Sanofi S.A.
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Teva Pharmaceuticals
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. AbbVie Inc. (Allergan plc)
11.3.12.1. Overview
11.3.12.2. Segments and Product
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
11.3.13. Purdue Pharmaceuticals L.P.
11.3.13.1. Overview
11.3.13.2. Segments and Product
11.3.13.3. Key Financials
11.3.13.4. Market Developments
11.3.13.5. Market Strategy
11.3.14. Sun Pharmaceutical Industries Ltd.
11.3.14.1. Overview
11.3.14.2. Segments and Product
11.3.14.3. Key Financials
11.3.14.4. Market Developments
11.3.14.5. Market Strategy
11.3.15. Mallinckrodt Pharmaceuticals
11.3.15.1. Overview
11.3.15.2. Segments and Product
11.3.15.3. Key Financials
11.3.15.4. Market Developments
11.3.15.5. Market Strategy
11.3.16. Endo Pharmaceuticals Inc. [Endo International plc]
11.3.16.1. Overview
11.3.16.2. Segments and Product
11.3.16.3. Key Financials
11.3.16.4. Market Developments
11.3.16.5. Market Strategy
11.3.17. Assertio Therapeutics, Inc. [Assertio Holdings, Inc.]
11.3.17.1. Overview
11.3.17.2. Segments and Product
11.3.17.3. Key Financials
11.3.17.4. Market Developments
11.3.17.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
